Neuromodulation Devices Market to Hit $14.16 Billion by 2030, Growing at a CAGR of 10.29%
September 05, 2022 08:40 ET
|
STRATEGIC MARKET RESEARCH LLP
New York, USA, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The Worldwide Neuromodulation Devices Market value was USD 6.10 Billion in 2021 and will reach USD 14.16 Billion in 2030 with a 10.29% CAGR....
Axsome Therapeutics Initiates EMERGE Phase 3 Open-Label Trial of AXS-07 for the Acute Treatment of Migraine in Adults with a Prior Inadequate Response to an Oral CGRP Inhibitor
September 01, 2022 07:00 ET
|
Axsome Therapeutics, Inc.
NEW YORK, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Global Neuromodulation Market to Reach $4.3 Bn Globally, by 2030, at 6.2% CAGR: Says AMR
June 15, 2022 07:47 ET
|
Allied Market Research
Portland, OR, June 15, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Neuromodulation Market was estimated at $2.48 billion in 2020, and is...
New West Dental Ceramics Launches Sleep and Migraine Appliances, New Blog
May 19, 2022 11:00 ET
|
New West Dental Ceramics
LAKE HAVASU CITY, Ariz., May 19, 2022 (GLOBE NEWSWIRE) -- New West Dental Ceramics has always been dedicated to providing superior dental services to its customers. This quarter, the dental lab has...
Migraine Market Size, Growth, Trends [2022-2029] | Global Industry Share, Key Players, Demand, Type & Application, Market Dynamics, Sales, Revenue, Price and Gross Margin, Supply Chain and Forecast Research | Market Reports World
April 25, 2022 05:17 ET
|
Market Reports World
Pune, April 25, 2022 (GLOBE NEWSWIRE) -- The global Migraine Market 2022 research report provides an in-depth analysis of market size, share, growth, trends and forecast. The Migraine Market...
New Accuracy in Media Award For Depiction of Migraine and Headache Disorders in Film and TV
March 08, 2022 12:53 ET
|
National Headache Foundation
Chicago, IL, March 08, 2022 (GLOBE NEWSWIRE) -- The National Headache Foundation (NHF) announced a new annual award, the Ellen Aubry Memorial Award, to recognize the accurate depiction of headache...
NHF Calls on Congress and Federal Agencies to Conduct Oversight Of Current Care Models for Migraine Patients
February 03, 2022 14:44 ET
|
National Headache Foundation
Chicago, IL, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Tom Dabertin, Chief Executive Officer/Executive Director of the National Headache Foundation (NHF) is calling on members of Congress and regulatory...
CenExel Clinical Research Acquires California Neuroscience Research
January 10, 2022 13:10 ET
|
CenExel Clinical Research
Salt Lake City, Utah, Jan. 10, 2022 (GLOBE NEWSWIRE) -- CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of California Neuroscience Research (“CenExel CNR”), a clinical...
Chronic Pain Market to Surpass US$ 108,814 Million by 2028, Says Coherent Market Insights (CMI)
November 17, 2021 08:40 ET
|
CMI
SEATTLE, Nov. 17, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global chronic pain market is estimated to be valued at US$ 64,068 million in 2020 and is expected to exhibit a...
Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
November 08, 2021 07:00 ET
|
Axsome Therapeutics, Inc.
Company to host conference call today at 8:00 AM Eastern NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies...